Results 61 to 70 of about 130 (100)

[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]. [PDF]

Probl Endokrinol (Mosk), 2023
Ishmuratova AN, Abramov MA, Kuznetsov KO, Ivanyuta MV, Shakirova ZF, Kitapova AI, Usmonov MD, Chernousova LM, Valeeva LI, Kuznetsova AY, Baislamov AS, Shaihetdinova AR, Mirgaliev AA, Orozberdiev ST, Yakupova KI.   +14 more
europepmc   +1 more source

Personal rehabilitation programs in Parkinson’s Diseases [PDF]

, 2017
The results of clinical trial in sphere of medical rehabilitation have been shown. Researching of efficacy of individual rehabilitation programs was leaded in such neuro-degeneration as Parkinson’s disease. Effectiveness of rhythmic brain stimulation was
Быков, Ю. Н., Bykov, Y. N., Bender, Т. В., Бендер, Т. Б.   +3 more
core  

МЕДИКО-СОЦИАЛЬНАЯ РЕАБИЛИТАЦИЯ, СИМПТОМАТИЧЕСКАЯ ТЕРАПИЯ И ОСОБЕННОСТИ БОЛЕЗНИ ПАРКИНСОНА

Болезнь Паркинсона — медленно прогрессирующее нейродегенеративное заболевание с накоплением альфа-синуклеина и формированием интранейрональных телец Леви.
Ахророва Шахло Ботировна, Абдурасулов Сардор Султанмуродович   +1 more
core  

Chemical destruction of vestibular receptors, as a method of neuromodulation for the treatment of neurological and mental symptoms of Parkinson’s disease

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
In work the modern view on questions of an etiology and pathogenesis of neurodegenerate diseases and in particular is provided to Parkinson’s disease. Outstanding performance of a method of a chemical destruction of vestibular receptors (CDVR) in case of
A. G. Naryshkin, I. V. Galanin, A. L. Gorelik, T. A. Skoromets, Y. O. Vikhreva   +4 more
doaj  

Development of a neural network for diagnosing the risk of depression according to the experimental data of the stop signal paradigm. [PDF]

Vavilovskii Zhurnal Genet Selektsii, 2022
Zelenskih MO, Saprygin AE, Rudych PD, Lebedkin DA, Savostyanov AN.   +4 more
europepmc   +1 more source

Вивчення показників поширеності та захворюваності на хворобу Паркінсона у різних регіонах світу

, 2017
Aim. To study the prevalence and incidence of Parkinson’s disease in 5 world regions and rank them by indexes of the prevalence and incidence.Materials and methods.
O. S. Prokopenko, Kotvitska, A. A., Prokopenko, O. S., A. A. Kotvitska   +3 more
core   +1 more source

Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease

Качественная клиническая практика, 2018
Objective. Health economic expertise of pramipexole extended release monotherapy at early stages of Parkinson’s disease. Methods. An economic model was developed based on clinical studies to derive comparative information on the effectiveness, utility ...
D. Yu. Belousov, E. V. Afanasyeva
doaj  

[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]

Probl Endokrinol (Mosk), 2022
Khovasova NO, Dudinskaya EN, Naumov AV, Tkacheva ON, Machekhina LV, Onuchina JS.   +5 more
europepmc   +1 more source

Quantifying human genome parameters in aging. [PDF]

Vavilovskii Zhurnal Genet Selektsii, 2023
Volobaev VP, Kunizheva SS, Uralsky LI, Kupriyanova DA, Rogaev EI.   +4 more
europepmc   +1 more source

НЕПОСРЕДСТВЕННОЕ ВЛИЯНИЕ АЦЕТИЛХОЛИНА НА БОЛЕЗНЬ ПАРКИНСОНА

Acetylcholine is the main neurotransmitter of the parasympathetic autonomic nervous system, as an internal transmitter for the sympathetic nervous system and a final product secreted by the parasympathetic autonomic nervous system. In the central nervous
Альхеджой Хасан, Абрамович Р.А., Альшарида З., Потанина О.Г.   +3 more
core